{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:40:30Z","timestamp":1790797230570,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chicago Medical School"},{"DOI":"10.13039\/100005725","name":"CHDI Foundation, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.niox.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:49:48Z","timestamp":1544014188000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-3168","authenticated-orcid":false,"given":"Fernando E.","family":"Padovan-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jurkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Stutzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-2175","authenticated-orcid":false,"given":"Vahri","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2018.12.002_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.niox.2018.12.002_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity\u2010akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann. Neurol."},{"issue":"5334","key":"10.1016\/j.niox.2018.12.002_bib3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.niox.2018.12.002_bib4","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"12","key":"10.1016\/j.niox.2018.12.002_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.niox.2018.12.002_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00112","article-title":"nNOS (+) striatal neurons, a subpopulation spared in Huntington's Disease, possess functional NMDA receptors but fail to generate mitochondrial ROS in response to an excitotoxic challenge","volume":"4","author":"Canzoniero","year":"2013","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-0173(00)00039-4","article-title":"Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease","volume":"34","author":"Cicchetti","year":"2000","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.niox.2018.12.002_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res."},{"issue":"4725","key":"10.1016\/j.niox.2018.12.002_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"1985","author":"Ferrante","year":"1985","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.niox.2018.12.002_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1212\/WNL.50.1.252","article-title":"Frontal lobe volume in patients with Huntington's disease","volume":"50","author":"Aylward","year":"1998","journal-title":"Neurol."},{"issue":"10","key":"10.1016\/j.niox.2018.12.002_bib12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurol."},{"key":"10.1016\/j.niox.2018.12.002_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2016.00317","article-title":"Corticostriatal dysfunction in Huntington's disease: the basics","volume":"10","author":"Bunner","year":"2016","journal-title":"Front. Hum. Neurosci."},{"issue":"7","key":"10.1016\/j.niox.2018.12.002_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","article-title":"Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease","volume":"19","author":"Sepers","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.niox.2018.12.002_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.niox.2018.12.002_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00313747","article-title":"Huntington's chorea\u2014measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid","volume":"225","author":"Cramer","year":"1981","journal-title":"J. Neurol."},{"key":"10.1016\/j.niox.2018.12.002_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.niox.2018.12.002_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington' s disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.niox.2018.12.002_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0306-4522(95)00596-X","article-title":"Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease","volume":"72","author":"Norris","year":"1996","journal-title":"Neuroscience"},{"issue":"28","key":"10.1016\/j.niox.2018.12.002_bib20","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1523\/JNEUROSCI.4699-13.2014","article-title":"Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits","volume":"34","author":"McKinstry","year":"2014","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.niox.2018.12.002_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.niox.2018.12.002_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.niox.2018.12.002_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-009-1687-0","article-title":"Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity","volume":"207","author":"Hoque","year":"2010","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.niox.2018.12.002_bib24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1460-9568.2008.06157.x","article-title":"Feed-forward excitation of striatal neuron activity by frontal cortical activation of nitric oxide signaling in vivo","volume":"27","author":"Ondracek","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.niox.2018.12.002_bib25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1471-4159.2009.06416.x","article-title":"Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions","volume":"111","author":"Park","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.niox.2018.12.002_bib26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.04811.x","article-title":"Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS\u2010dependent mechanism","volume":"103","author":"Sammut","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.niox.2018.12.002_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2011.00055","article-title":"Nitric oxide\u2013soluble guanylyl cyclase\u2013cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease?","volume":"5","author":"West","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.niox.2018.12.002_bib28","series-title":"Handbook of Basal Ganglia Structure and Function, a Decade of Progress","article-title":"Nitric oxide signaling in the striatum","author":"West","year":"2016"},{"issue":"14","key":"10.1016\/j.niox.2018.12.002_bib29","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1523\/JNEUROSCI.1238-14.2015","article-title":"Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways","volume":"35","author":"Padovan-Neto","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0306-4522(93)90294-P","article-title":"Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease","volume":"53","author":"Morton","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2018.12.002_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jnr.1057","article-title":"Nitric oxide and nitric oxide synthase in Huntington's disease","volume":"64","author":"Deckel","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.expneurol.2008.05.015","article-title":"Adenosine A 2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice","volume":"213","author":"Cipriani","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(01)03000-1","article-title":"Reduced activity and protein expression of NOS in R6\/2 HD transgenic mice: effects of L-NAME on symptom progression","volume":"919","author":"Deckel","year":"2001","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(02)02550-7","article-title":"Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice","volume":"939","author":"Deckel","year":"2002","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)03102-5","article-title":"Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation","volume":"951","author":"Perez-Severiano","year":"2002","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.niox.2018.12.002_bib36","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J. Neurophysiol. (Bethesda)"},{"issue":"11","key":"10.1016\/j.niox.2018.12.002_bib37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington's disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.niox.2018.12.002_bib38","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2018.12.002_bib39","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2012"},{"key":"10.1016\/j.niox.2018.12.002_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/syn.21503","article-title":"Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens","volume":"66","author":"Hoque","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.niox.2018.12.002_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2202-10-5","article-title":"Statistical evaluation of methods for quantifying gene expression by autoradiography in histological sections","volume":"10","author":"Lazic","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.niox.2018.12.002_bib42","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.88.17.7797","article-title":"Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2018.12.002_bib43","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1073\/pnas.88.7.2811","article-title":"Neuronal NADPH diaphorase is a nitric oxide synthase","volume":"88","author":"Hope","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2018.12.002_bib44","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0028-3908(97)00159-7","article-title":"Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release","volume":"36","author":"Morris","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2018.12.002_bib45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","article-title":"Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation","volume":"20","author":"Sancesario","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.niox.2018.12.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2017.09.005","article-title":"Electrical stimulation of the hippocampal fimbria facilitates neuronal nitric oxide synthase activity in the medial shell of the rat nucleus accumbens: modulation by dopamine D1 and D2 receptor activation","author":"Hoque","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2018.12.002_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.npp.1300826","article-title":"Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1\/5) receptor-dependent mechanism","volume":"31","author":"Sammut","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.niox.2018.12.002_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-006-0681-z","article-title":"Dopamine D(2) receptor-dependent modulation of striatal NO synthase activity","volume":"191","author":"Sammut","year":"2007","journal-title":"Psychopharmacol."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.niox.2018.12.002_bib50","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2018.12.002_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-0102(96)01134-0","article-title":"Neostriatal cell subtypes and their functional roles","volume":"27","author":"Kawaguchi","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.niox.2018.12.002_bib52","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1523\/JNEUROSCI.2440-12.2012","article-title":"Relationships between the firing of identified striatal interneurons and spontaneous and driven cortical activities in vivo","volume":"32","author":"Sharott","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.niox.2018.12.002_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(96)00433-2","article-title":"Cortical afferents modulate striatal gap junction permeability via nitric oxide","volume":"76","author":"O'Donnell","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2018.12.002_bib54","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuropharm.2009.11.011","article-title":"Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo","volume":"58","author":"Sammut","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2018.12.002_bib55","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1523\/JNEUROSCI.4470-03.2004","article-title":"The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo","volume":"24","author":"West","year":"2004","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.niox.2018.12.002_bib56","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jnr.23980","article-title":"Sex\u2010specific effects of the Huntington gene on normal neurodevelopment","volume":"95","author":"Lee","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"8","key":"10.1016\/j.niox.2018.12.002_bib57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmg.28.8.515","article-title":"Age at onset in Huntington's disease: effect of line of inheritance and patient's sex","volume":"28","author":"Roos","year":"1991","journal-title":"J. Med. Genet."},{"issue":"17","key":"10.1016\/j.niox.2018.12.002_bib58","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.niox.2018.12.002_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gt.2015.113","article-title":"AAV1\/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease","volume":"23","author":"Connor","year":"2016","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.niox.2018.12.002_bib60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.niox.2018.12.002_bib61","doi-asserted-by":"crossref","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","article-title":"Sex differences in circadian dysfunction in the BACHD mouse model of Huntington's disease","volume":"11","author":"Kuljis","year":"2016","journal-title":"PloS One"}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318301228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318301228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:39:14Z","timestamp":1565246354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860318301228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":61,"alternative-id":["S1089860318301228"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2018.12.002","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}